Sort
23,748 grants matching “melanoma”
Outreach Core
$148,888Claudia Ludwig · Institute For Systems Biology · U54 · FY2022 · CA
Project 1: How tumor ensemble models with two experimental models predict tumor dormancy & reactivation in cancers with gender and/or ethnic disparities
$148,845David Rumschitzki · City College Of New York · U54 · FY2019 · CA
Targeted Drug Delivery via Microparticle-Drug Conjugates
$148,778University Of Illinois At Chicago · R03 · FY2003 · EY
Immune targeting of melanoma-associated antigens in glioma
$148,770Robert M Prins · University Of California Los Angeles · K01 · FY2009 · CA
Immune targeting of melanoma-associated antigens in glioma
$148,770Robert M Prins · University Of California Los Angeles · K01 · FY2010 · CA
SOCS proteins as inhibitors of immune surveillance in the melanoma microenvironme
$148,770Gregory B. Lesinski · Ohio State University · K22 · FY2008 · CA
Immune targeting of melanoma-associated antigens in glioma
$148,770Robert M Prins · University Of California Los Angeles · K01 · FY2008 · CA
Novel Mechanisms in the Resolution of Post-Surgical Lymphedema
$148,759Aladdin Hasan Hassanein · Indiana University Indianapolis · K08 · FY2024 · HL
Novel Mechanisms in the Resolution of Post-Surgical Lymphedema
$148,759Aladdin Hasan Hassanein · Indiana University Indianapolis · K08 · FY2023 · HL
Novel Mechanisms in the Resolution of Post-Surgical Lymphedema
$148,759Aladdin Hasan Hassanein · Indiana University Indianapolis · K08 · FY2025 · HL
CANCER AND ACUTE LEUKEMIA GROUP B (CALGB) INST GRANT
$148,735Georgetown University · U10 · FY2000 · CA
Senior Leadership
$148,700Dario C. Altieri · Wistar Institute · P30 · FY2017 · CA
RNA Interference Tools Core
$148,641Pedro Aza-Blanc · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2009 · CA
Impact of Melanoma Genetic Testing on Health Cognitions and Prevention Behaviors
$148,619Lisa G Aspinwall · University Of Utah · R01 · FY2014 · CA
Two photon microscopy and optical clearing for volumetric imaging of melanoma surgical margins
$148,600Michael Gene Giacomelli · University Of Rochester · R21 · FY2023 · EB
ROLE OF EWS ATF1 IN NEOPLASIA
$148,567Drexel University · R01 · FY2002 · CA
Targeting RAS in Pediatric Cancer
$148,559Marielle Yohe · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Regulation of tumor growth and metabolism by hyperinsulinemia
$148,502Rachel Jamison Perry · Yale University · K99 · FY2017 · CA
A High Throughput Assay Targeting Beta Catenin and TCF
$148,500University Of Maryland Baltimore · R21 · FY2002 · CA
Outreach Core
$148,432Claudia Ludwig · Institute For Systems Biology · U54 · FY2023 · CA
CYTOKINES AS CANCER IMMUNOTHERAPEUTICS
$148,417University Of South Florida · R29 · FY2001 · CA
TUMOR VACCINES FOR THE TREATMENT OF ORAL MELANOMA
$148,379University Of Wisconsin Madison · R01 · FY2002 · DE
Optimization of Tannic Acid Lipid Nanoparticles for a Therapeutic mRNA Vaccine Against Melanoma
$148,334Owen S Fenton · Univ Of North Carolina Chapel Hill · R21 · FY2025 · EB
Targeted Advertising for Cancer Prevention
$148,253Eleni Linos · University Of California, San Francisco · DP2 · FY2018 · CA
Autologous Humanized Mouse Model of Non-Small Cell Lung Cancer (NSCLC) to Investigate the Tumor-Immune Landscape and Its Response to Treatment
$148,177Michael Chiorazzi · Yale University · K08 · FY2021 · CA